Sigma-Tau Finanziaria (Oncaspar Product) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Sigma-Tau Finanziaria (Oncaspar Product) General Information

Description

A portfolio of cancer treatment products. The assets is a biologic cancer therapy used as a component of multi-agent chemotherapeutic regimens to treat acute lymphoblastic leukemia (ALL), a rapidly progressing cancer of the white blood cells. It is primarily marketed in the United States, Germany, Poland and certain other countries and is currently under centralized marketing authorization review with the European Medicines Agency.

Contact Information

Website
www.oncaspar.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Gaithersburg, MD 20878
  • United States
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Acquirer
Baxalta
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Gaithersburg, MD 20878
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sigma-Tau Finanziaria (Oncaspar Product) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sigma-Tau Finanziaria (Oncaspar Product)‘s full profile, request access.

Request a free trial

Sigma-Tau Finanziaria (Oncaspar Product) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
A portfolio of cancer treatment products. The assets is a biologic cancer therapy used as a component of multi-agent che
Buildings and Property
Gaithersburg, MD

San Mateo, CA
 

Novato, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sigma-Tau Finanziaria (Oncaspar Product) Competitors (2)

One of Sigma-Tau Finanziaria (Oncaspar Product)’s 2 competitors is Sagimet Biosciences, a Formerly VC-backed company based in San Mateo, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sagimet Biosciences Formerly VC-backed San Mateo, CA
Ultragenyx Pharmaceutical Formerly VC-backed Novato, CA
You’re viewing 2 of 2 competitors. Get the full list »

Sigma-Tau Finanziaria (Oncaspar Product) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sigma-Tau Finanziaria (Oncaspar Product)‘s full profile, request access.

Request a free trial

Sigma-Tau Finanziaria (Oncaspar Product) FAQs

  • Where is Sigma-Tau Finanziaria (Oncaspar Product) headquartered?

    Sigma-Tau Finanziaria (Oncaspar Product) is headquartered in Gaithersburg, MD.

  • What industry is Sigma-Tau Finanziaria (Oncaspar Product) in?

    Sigma-Tau Finanziaria (Oncaspar Product)’s primary industry is Buildings and Property.

  • Is Sigma-Tau Finanziaria (Oncaspar Product) a private or public company?

    Sigma-Tau Finanziaria (Oncaspar Product) is a Private company.

  • What is the current valuation of Sigma-Tau Finanziaria (Oncaspar Product)?

    The current valuation of Sigma-Tau Finanziaria (Oncaspar Product) is .

  • What is Sigma-Tau Finanziaria (Oncaspar Product)’s current revenue?

    The current revenue for Sigma-Tau Finanziaria (Oncaspar Product) is .

  • Who are Sigma-Tau Finanziaria (Oncaspar Product)’s investors?

    Sigma Tau Finanziaria has invested in Sigma-Tau Finanziaria (Oncaspar Product).

  • Who are Sigma-Tau Finanziaria (Oncaspar Product)’s competitors?

    Sagimet Biosciences and Ultragenyx Pharmaceutical are competitors of Sigma-Tau Finanziaria (Oncaspar Product).

  • When was Sigma-Tau Finanziaria (Oncaspar Product) acquired?

    Sigma-Tau Finanziaria (Oncaspar Product) was acquired on 23-Jul-2015.

  • Who acquired Sigma-Tau Finanziaria (Oncaspar Product)?

    Sigma-Tau Finanziaria (Oncaspar Product) was acquired by Baxalta.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »